Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

RCGP animation to improve patient care

Encourages doctors to consider a holistic approach to care planning

- PMLiVE

Novo Nordisk’s Xultophy debuts in Switzerland

It is the first market for combination of diabetes treatments Tresiba and Victoza

Roche Basel Switzerland

Roche buys rare disease firm Trophos in €470m deal

Will take control of olesoxime for spinal muscular atrophy

- PMLiVE

A baptism of fire for Europe’s new health commissioner

Controversial trade deals, the spread of Ebola and the threat of austerity are just three of the issues facing Dr Vytenis Andriukaitis

- PMLiVE

MedDay appoints former Sanofi VP to board

Philippe Goupit joins French biotech

- PMLiVE

Janssen will cover cost of unsuccessful hepatitis C treatment

NHS England will only have to pay for Olysio if patient clears virus

- PMLiVE

NICE backs new hepatitis C treatments

But Sovaldi faces funding delay and Olysio not backed in all indications

- PMLiVE

EC clears AbbVie’s oral hepatitis C regimen

Viekirax and Exviera offer competition to Gilead’s Sovaldi

- PMLiVE

Clinical data sharing ‘should be the norm’, says IoM

US Institute pitches into clinical data transparency debate

EU flag

Pharma joins European Alzheimer’s research initiative

Lilly and Janssen among participants of dementia-focused IMI project

- PMLiVE

US hospital firm HCA appoints chief patient experience officer

Lyn Ketelsen will lead improvement of patient experience

- PMLiVE

Nurturing change in pharma marketing

Multichannel pharma marketing could be ready to hatch

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links